Clinical Trial Update: Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor [Phase 2]

View source ↗

Summary

A Phase 2 trial for patients with recurrent non-small cell lung cancer after prior chemotherapy and surgical tumor removal was terminated; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Lung Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2009-07-29